We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

124 hedge funds and large institutions have $633M invested in AnaptysBio in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,356% more call options, than puts

Call options by funds: $5.03M | Put options by funds: $205K

3.25% more ownership

Funds ownership: 107.31% → 110.55% (+3.2%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 39

5% less funds holding

Funds holding: 131 → 124 (-7)

14% less capital invested

Capital invested by funds: $733M → $633M (-$100M)

14% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 21

Holders
124
Holders Change
-7
Holders Change %
-5.34%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
39
Reduced
39
Closed
21
Calls
$5.03M
Puts
$205K
Net Calls
+$4.83M
Net Calls Change
+$4.47M

Top Buyers

1
DM
Deerfield Management
New York
+$17.1M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$15.5M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$15.2M
4
SCM
Soleus Capital Management
Connecticut
+$14.3M
5
State Street
State Street
Massachusetts
+$4.38M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$10.3M
2
LGM
Logos Global Management
California
-$7.42M
3
GPP
Great Point Partners
Connecticut
-$5.47M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3.78M
5
N
Nuveen
North Carolina
-$3.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
EP
26
Eversept Partners
New York
$3.71M +$1.52M +68,552 +60%
Morgan Stanley
27
Morgan Stanley
New York
$2.98M +$923K +41,664 +40%
Charles Schwab
28
Charles Schwab
California
$2.89M +$5.98K +270 +0.2%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$2.66M -$851K -38,408 -23%
Fidelity Investments
30
Fidelity Investments
Massachusetts
$2.66M -$1.06M -48,029 -27%
Goldman Sachs
31
Goldman Sachs
New York
$2.29M -$2.59M -116,974 -51%
ECM
32
ExodusPoint Capital Management
New York
$2.19M +$668K +30,178 +39%
Macquarie Group
33
Macquarie Group
Australia
$1.91M – – –
UOC
34
UBS O'Connor
Illinois
$1.64M +$1.79M +80,966 New
Fisher Asset Management
35
Fisher Asset Management
Washington
$1.57M +$214K +9,651 +14%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.57M -$166K -7,473 -9%
Connor, Clark & Lunn Investment Management (CC&L)
37
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.49M -$114K -5,149 -7%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$1.24M -$357K -16,100 -21%
JAM
39
Jupiter Asset Management
United Kingdom
$1.21M -$15.1K -681 -1%
TCM
40
TCG Crossover Management
California
$1.19M – – –
Ameriprise
41
Ameriprise
Minnesota
$1.11M -$13.3K -599 -1%
CAM
42
Cormorant Asset Management
Massachusetts
$1.01M – – –
Squarepoint
43
Squarepoint
New York
$973K +$1.06M +47,911 New
Bank of America
44
Bank of America
North Carolina
$943K +$272K +12,270 +36%
HF
45
HRT Financial
New York
$932K +$1.02M +45,932 New
Ensign Peak Advisors
46
Ensign Peak Advisors
Utah
$921K – – –
Citigroup
47
Citigroup
New York
$839K +$703K +31,746 +331%
Swiss National Bank
48
Swiss National Bank
Switzerland
$794K -$70.9K -3,200 -8%
Rafferty Asset Management
49
Rafferty Asset Management
New York
$792K -$168K -7,565 -16%
Jane Street
50
Jane Street
New York
$765K +$835K +37,680 New
1
2
3 4 5

ANAB Hedge Fund Activity: Q2 2022 in Review

124 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q2 2022, worth a combined $633M — down 14% from $733M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ANAB and 18 opened new positions — a net loss of 3 holders — while 39 trimmed existing stakes and 39 added.

The largest buyer was Deerfield Management, opening a new position worth an estimated $17.1M. The largest seller was Point72 Asset Management, cutting an estimated $10.3M.

  • 124 institutional investors held AnaptysBio (ANAB) as of Q2 2022, down from 131 in Q1 2022.
  • Funds reported $633M of AnaptysBio stock for Q2 2022, down 14% quarter-over-quarter.
  • 18 funds opened new AnaptysBio positions in Q2 2022 and 21 closed out, a net change of -3 holders.
  • The largest AnaptysBio buyer in Q2 2022 was Deerfield Management, an estimated $17.1M added.
  • The largest AnaptysBio seller in Q2 2022 was Point72 Asset Management, an estimated $10.3M sold.

Based on aggregated 13F filings for Q2 2022.